-
Je něco špatně v tomto záznamu ?
9-Norbornyl-6-chloropurine (NCP) induces cell death through GSH depletion-associated ER stress and mitochondrial dysfunction
P. Plačková, M. Šála, M. Šmídková, M. Dejmek, H. Hřebabecký, R. Nencka, HJ. Thibaut, J. Neyts, H. Mertlíková-Kaiserová,
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články, práce podpořená grantem
- MeSH
- apoptóza účinky léků MeSH
- glutamátcysteinligasa genetika MeSH
- glutathion metabolismus MeSH
- glutathiontransferasa genetika MeSH
- leukemie T-buněčná farmakoterapie genetika metabolismus patologie MeSH
- lidé MeSH
- mitochondrie účinky léků patologie MeSH
- NAD(P)H dehydrogenasa (chinon) genetika MeSH
- oxidační stres účinky léků MeSH
- peroxidace lipidů účinky léků MeSH
- puriny aplikace a dávkování MeSH
- reaktivní formy kyslíku metabolismus MeSH
- regulace genové exprese u leukemie účinky léků MeSH
- stres endoplazmatického retikula účinky léků MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
UNLABELLED: 9-Norbornyl-6-chloropurine (NCP) is a representative of a series of antienteroviral bicycle derivatives with selective cytotoxicity towards leukemia cell lines. In this work we explored the mechanism of the antileukemic activity of NCP in T-cell lymphoblast cells (CCRF-CEM). Specifically, we searched for a potential link between its ability to induce cell death on the one hand and to modulate intracellular glutathione (GSH) that is necessary to its metabolic transformation via glutathione-S-transferase on the other hand. We have observed that GSH levels decreased rapidly in NCP-treated cells. Despite a complete regeneration following 24h of incubation with NCP, this profound drop in cellular GSH content triggered ER stress, ROS production and lipid peroxidation leading to the loss of mitochondrial membrane potential (MMP). These events induced concentration-dependent cell cycle arrest in G2/M phase and apoptosis. Both MMP loss and apoptosis were reversed by sulfhydryl-containing compounds (GSH, N-acetyl-l-cysteine). Furthermore, we have also shown that NCP-induced GSH decrease activated the Nrf2 pathway and its downstream targets NAD(P)H: quinone oxidoreductase (NQO-1) and glutamate cysteine ligase modifier subunit (GCLm), thus explaining the fast restoration of GSH pool and ROS decrease. Importantly, we confirmed that the cell death-inducing properties of the compounds were co-dependent on their ability to diminish cellular GSH level by analyzing the relationships between the GSH-depleting potency and cytotoxicity in a series of other norbornylpurine analogs. Altogether, the results demonstrated that in CCRF-CEM cells NCP triggered apoptosis through GSH depletion-associated oxidative and ER stress and mitochondrial depolarization.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc18011164
- 003
- CZ-PrNML
- 005
- 20180809080120.0
- 007
- ta
- 008
- 180404s2016 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.freeradbiomed.2016.06.004 $2 doi
- 035 __
- $a (PubMed)27288283
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Plačková, Pavla $u Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, v.v.i., 166 10 Prague 6, Czech Republic.
- 245 10
- $a 9-Norbornyl-6-chloropurine (NCP) induces cell death through GSH depletion-associated ER stress and mitochondrial dysfunction / $c P. Plačková, M. Šála, M. Šmídková, M. Dejmek, H. Hřebabecký, R. Nencka, HJ. Thibaut, J. Neyts, H. Mertlíková-Kaiserová,
- 520 9_
- $a UNLABELLED: 9-Norbornyl-6-chloropurine (NCP) is a representative of a series of antienteroviral bicycle derivatives with selective cytotoxicity towards leukemia cell lines. In this work we explored the mechanism of the antileukemic activity of NCP in T-cell lymphoblast cells (CCRF-CEM). Specifically, we searched for a potential link between its ability to induce cell death on the one hand and to modulate intracellular glutathione (GSH) that is necessary to its metabolic transformation via glutathione-S-transferase on the other hand. We have observed that GSH levels decreased rapidly in NCP-treated cells. Despite a complete regeneration following 24h of incubation with NCP, this profound drop in cellular GSH content triggered ER stress, ROS production and lipid peroxidation leading to the loss of mitochondrial membrane potential (MMP). These events induced concentration-dependent cell cycle arrest in G2/M phase and apoptosis. Both MMP loss and apoptosis were reversed by sulfhydryl-containing compounds (GSH, N-acetyl-l-cysteine). Furthermore, we have also shown that NCP-induced GSH decrease activated the Nrf2 pathway and its downstream targets NAD(P)H: quinone oxidoreductase (NQO-1) and glutamate cysteine ligase modifier subunit (GCLm), thus explaining the fast restoration of GSH pool and ROS decrease. Importantly, we confirmed that the cell death-inducing properties of the compounds were co-dependent on their ability to diminish cellular GSH level by analyzing the relationships between the GSH-depleting potency and cytotoxicity in a series of other norbornylpurine analogs. Altogether, the results demonstrated that in CCRF-CEM cells NCP triggered apoptosis through GSH depletion-associated oxidative and ER stress and mitochondrial depolarization.
- 650 _2
- $a apoptóza $x účinky léků $7 D017209
- 650 _2
- $a stres endoplazmatického retikula $x účinky léků $7 D059865
- 650 _2
- $a regulace genové exprese u leukemie $x účinky léků $7 D015973
- 650 _2
- $a glutamátcysteinligasa $x genetika $7 D005721
- 650 _2
- $a glutathion $x metabolismus $7 D005978
- 650 _2
- $a glutathiontransferasa $x genetika $7 D005982
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a leukemie T-buněčná $x farmakoterapie $x genetika $x metabolismus $x patologie $7 D015458
- 650 _2
- $a peroxidace lipidů $x účinky léků $7 D015227
- 650 _2
- $a mitochondrie $x účinky léků $x patologie $7 D008928
- 650 _2
- $a NAD(P)H dehydrogenasa (chinon) $x genetika $7 D016660
- 650 _2
- $a oxidační stres $x účinky léků $7 D018384
- 650 _2
- $a puriny $x aplikace a dávkování $7 D011687
- 650 _2
- $a reaktivní formy kyslíku $x metabolismus $7 D017382
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Šála, Michal $u Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, v.v.i., 166 10 Prague 6, Czech Republic.
- 700 1_
- $a Šmídková, Markéta, $d 1974- $7 xx0226455 $u Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, v.v.i., 166 10 Prague 6, Czech Republic.
- 700 1_
- $a Dejmek, Milan $u Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, v.v.i., 166 10 Prague 6, Czech Republic.
- 700 1_
- $a Hřebabecký, Hubert $u Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, v.v.i., 166 10 Prague 6, Czech Republic.
- 700 1_
- $a Nencka, Radim $u Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, v.v.i., 166 10 Prague 6, Czech Republic.
- 700 1_
- $a Thibaut, Hendrik-Jan $u Rega Institute for Medical Research, KU Leuven, Minderbroedersstraat 10, BE-3000 Leuven, Belgium.
- 700 1_
- $a Neyts, Johan $u Rega Institute for Medical Research, KU Leuven, Minderbroedersstraat 10, BE-3000 Leuven, Belgium.
- 700 1_
- $a Mertlíková-Kaiserová, Helena $u Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, v.v.i., 166 10 Prague 6, Czech Republic. Electronic address: mertlikova@uochb.cas.cz.
- 773 0_
- $w MED00001857 $t Free radical biology & medicine $x 1873-4596 $g Roč. 97, č. - (2016), s. 223-235
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/27288283 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20180404 $b ABA008
- 991 __
- $a 20180809080444 $b ABA008
- 999 __
- $a ok $b bmc $g 1288649 $s 1007976
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2016 $b 97 $c - $d 223-235 $e 20160607 $i 1873-4596 $m Free radical biology & medicine $n Free Radic Biol Med $x MED00001857
- LZP __
- $a Pubmed-20180404